Why Higher Drug Costs Are Consumers’ Biggest Cost Worry

In his latest column for The Wall Street Journal’s Think Tank, Drew Altman discusses why public concern over drug prices is the “tip of the iceberg” representing broader concerns about out-of-pocket health care costs.

All previous columns by Drew Altman are available online.

Read the Column